|
|
|
|
 |
|
Human
Genome News Archive Edition |
|
|
Sponsored
by the U.S. Department of
Energy Human Genome Program
|
Human Genome News, October-December 1996; 8:(2)
An overview of challenges facing gene therapy is presented in a special feature of the September 10, 1996, issue of Human Gene Therapy (7, 1781-90). "Gene Therapy in the United States: A Five-Year Status Report" concludes that it clearly is too early to assess the therapeutic efficacy of gene therapy or even to predict its promise. Although the public is excited about novel medical cures and some measure of success has been achieved in certain technical aspects of gene transfer, the report says that gene therapy is still at an early stage. Nearly all the gene-therapy studies consist of Phase I trials, with the goal of establishing the procedure's safety rather than its effectiveness. [Article reprints: Brian R. Smith; Yale University School of Medicine; 333 Cedar Street, P.O. Box 208035; New Haven, CT 06520-8035]
Return to the Table of Contents
The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v8n2).
Send the url of this page to a friend
Last modified: Wednesday, October 29, 2003
Home * Contacts * Disclaimer
Base URL: www.ornl.gov/hgmis
Site sponsored by the U.S. Department of Energy
Office of Science, Office
of Biological and Environmental Research, Human
Genome Program
